Parkridge Medical Center, INC.

Parkridge Medical Center, INC. was paid $26.86M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 99283, emergency room visit (moderate) — 58% of everything it billed.

33Billing provider infoPARKRIDGE MEDICAL CENTER, INC.
CHATTANOOGA, TN 37404

33aNPI1104874684assigned 05/05/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$26.86M

24GClaims376,576

24DCodes billed80

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Tennessee

Rank by total paid#10 of 71

Median peer was paid$6.96M

This provider vs. median3.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	46,403	$3.67M
2019	48,316	$3.73M
2020	42,525	$2.96M
2021	54,935	$3.85M
2022	59,888	$4.48M
2023	77,795	$4.75M
2024incomplete	46,714	$3.43M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	58%	77,367	66,769	$15.66M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	31%	39,515	31,956	$8.28M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.5%	21,995	17,808	$662K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	2.1%	1,614	1,115	$570K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.9%	4,307	3,803	$499K
45380	Colonoscopy, flexible; with biopsy, single or multiple	1.5%	908	614	$413K
G0378	Hospital observation service, per hour	<1%	581	410	$214K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	11,784	9,657	$165K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	<1%	767	588	$158K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	2,968	2,770	$45K
96375	Therapeutic injection; each additional sequential IV push	<1%	5,282	4,212	$31K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	506	447	$21K

68 more codes

87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	664	$16K
80053	Comprehensive metabolic panel	<1%	30,897	$14K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	8,479	$14K
43248		<1%	36	$13K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	359	$13K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	278	$8K
87430		<1%	3,045	$7K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	79	$7K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	14,245	$6K
84484		<1%	9,943	$5K
85027		<1%	45,129	$5K
80048	Basic metabolic panel (calcium, ionized)	<1%	8,368	$3K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	53	$3K
71045	Radiologic examination, chest; single view	<1%	12,300	$3K
71046	Radiologic examination, chest; 2 views	<1%	1,492	$3K
81001		<1%	18,548	$2K
84703		<1%	10,810	$2K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,579	$1K
83655		<1%	29	$988.81
70450	Computed tomography, head or brain; without contrast material	<1%	271	$839.10
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	236	$683.54
83690		<1%	6,352	$671.16
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	17	$640.44
J7030	Infusion, normal saline solution , 1000 cc	<1%	7,429	$626.83
87070		<1%	326	$359.99
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	205	$327.47
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	5,253	$300.67
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,392	$240.00
83735		<1%	1,461	$227.24
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,104	$217.87
85018		<1%	28	$200.08
36415	Collection of venous blood by venipuncture	<1%	303	$145.72
85610		<1%	1,638	$91.55
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	918	$86.42
87086	Culture, bacterial; quantitative colony count, urine	<1%	31	$65.20
85730		<1%	920	$57.36
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	168	$52.20
86710		<1%	338	$47.44
83880		<1%	139	$37.07
81003		<1%	4,325	$34.90
J7050	Infusion, normal saline solution, 250 cc	<1%	1,966	$27.39
86756		<1%	41	$25.07
87040		<1%	295	$20.22
J2270	Injection, morphine sulfate, up to 10 mg	<1%	370	$14.91
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,164	$13.00
80047		<1%	88	$12.80
85379		<1%	66	$11.23
83605		<1%	465	$11.21
J7120	Ringers lactate infusion, up to 1000 cc	<1%	562	$7.64
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	2,720	$4.10
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	0%	652	$0.00
G1003	Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program	0%	274	$0.00
85049		0%	32	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	24	$0.00
82248		0%	34	$0.00
73630		0%	12	$0.00
80061	Lipid panel	0%	15	$0.00
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	0%	41	$0.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	0%	15	$0.00
96361	Intravenous infusion, hydration; each additional hour	0%	128	$0.00
88342		0%	603	$0.00
82784		0%	52	$0.00
A9270	Non-covered item or service	0%	65	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	24	$0.00
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	0%	32	$0.00
J3490	Unclassified drugs	0%	13	$0.00
J1170	Injection, hydromorphone, up to 4 mg	0%	13	$0.00
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	29	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRIDGE, CAROLYN (CFO)